Bandingkan Harga & Kinerja Megapower Makmur Tbk. (MPOW) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Megapower Makmur Tbk. dan Organon Pharma Indonesia Tbk.: Megapower Makmur Tbk. diperdagangkan di Rp113 (kapitalisasi pasar 92,32 M, volume 24 jam 2,98 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Megapower Makmur Tbk. dan Organon Pharma Indonesia Tbk. berukuran mirip dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| MPOW | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 92,32 M | 104,4 M |
Volume | 2,98 jt | — |
Lot | 29,77 rb | — |
Perputaran | 331,73 jt | — |
Harga Rata-rata | 111,41 | — |
Nilai Transaksi | 331,73 jt | — |
Harga Ekuilibrium Indikatif | 113 | — |
Volume Ekuilibrium Indikatif | 789 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Megapower Makmur Tbk.
PT Megapower Makmur Tbk (the Company) was established based on notarial deed No. 05 dated August 1, 2007 and amended with deed No. 160 dated September 19, 2007, both made in front of Ms. Rose Takarina, S.H., notary in Jakarta. In 2010, Megapower Makmur had acquired by Bina Puri Holdings Bhd and start investing through Power plant in one of the Indonesia shortage of electricity area. In 2012, Megapower Makmur totally has become an Indonesia IPP (Independent Power Producer) Company. Megapower Makmur currently is a subsidiary of Bina Puri Holdings Bhd, a public company listed on the main board of Bursa Malaysia Berhad, with 40 years of work experience in the field of civil construction and the building of both local and international.
Selengkapnya di halaman MPOW →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
